Login / Signup

Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.

Pierre de FlonKatarina LaurellPeter SundströmKaj BlennowLars SöderströmHenrik ZetterbergMartin GunnarssonAnders Svenningsson
Published in: Acta neurologica Scandinavica (2019)
This study indicates that NFL in plasma is less sensitive as an endpoint in group comparisons than NFL in CSF. Given that plasma NFL is far easier to access, it is a promising and awaited method but further studies are needed to optimize the use in clinical trials.
Keyphrases
  • cerebrospinal fluid
  • clinical trial
  • multiple sclerosis
  • phase ii
  • phase iii
  • study protocol
  • randomized controlled trial
  • white matter
  • open label